Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
48,492,363
-
Shares change
-
+3,710,314
-
Total reported value, excl. options
-
$962,430,435
-
Value change
-
+$75,895,459
-
Put/Call ratio
-
49.58%
-
Number of buys
-
68
-
Number of sells
-
-64
-
Price
-
$19.85
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2018
177 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2018.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48,492,363 shares
of 117,273,296 outstanding shares and own 41.35% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (5,063,934 shares), STATE STREET CORP (4,490,070 shares), BlackRock Inc. (3,864,788 shares), FRANKLIN RESOURCES INC (2,686,630 shares), VANGUARD GROUP INC (2,651,928 shares), FEDERATED INVESTORS INC /PA/ (2,422,429 shares), GMT CAPITAL CORP (2,210,837 shares), Consonance Capital Management LP (1,658,795 shares), venBio Select Advisor LLC (1,650,700 shares), and D. E. Shaw & Co., Inc. (1,646,283 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.